Prof I Mhairi Macrae

- Professor of Neuroscience (Stroke and Brain Imaging)
telephone: 01413306978
email: Mhairi.Macrae@glasgow.ac.uk
Mhairi Macrae is a neuroscientist with an undergraduate and post-graduate degree in Pharmacology from the University of Glasgow.
Her main research interest is in stroke and cerebral blood flow (CBF), studying ischaemic brain injury using in vivo rodent models, imaging techniques including MRI and behavioural testing.
She has expertise in the development of animal models of experimental stroke, in the measurement of CBF and ischaemic damage and in the assessment of neurological deficits and functional recovery. Her research has included studies of CBF, brain metabolism, cerebral autoregulation, oxidative stress, inflammation and stroke sensitivity genes.
She is Deputy Head of Stroke and Brain Imaging, with her group based in the neuroscience laboratories of the Wellcome Surgical Institute (WSI), Garscube Estate.
She is also Co-Director of the University of Glasgow Glasgow Experimental MRI Centre, situated adjacent to WSI in Garscube Estate.
Research
Current research interests related to stroke include the ischaemic penumbra, inflammation, hyperglycaemia and metabolic syndrome, stem cell therapy and the influence of ageing.
She has a particular interest in neuroprotection strategies in focal cerebral ischaemia which has included studies on glutamate antagonists, anti-oxidants and oestrogen. Her research also involves identification of mechanisms responsible for inducing brain damage during ischaemia and reperfusion, and those promoting brain repair and functional recovery.
A more recent research focus has been the use of MRI in neuroscience research with a particular interest in brain imaging.
Cerebral Blood Flow and the Ischaemic Penumbra
Aims & techniques: Investigation of the ischaemic penumbra and characterisation of changes in CBF is carried out in a range of experimental stroke models using blood flow autoradiography, laser Doppler flowmetry and, more recently, MRI techniques.
Collaborators: Debbie Dewar, Chris McCabe and William Holmes and Keith Muir (Centre for Stroke and Brain Imaging), Barrie Condon and David Brennan (Clinical Physics), Celestine Santosh and Donald Hadley (Neuroradiology), Lorraine Work (Institute of Cardiovascular and Medical Sciences)
Oxidative Stress and Inflammation
Aims & techniques: The role of oxidative stress and inflammation in stroke is studied in normotensive and hypertensive (SHRSP) rat strains using immunohistochemistry and histology techniques to identify inflammatory cells and oxidative damage.
Collaborators: Anna Dominiczak and her group (Division of Cardiovascular and Medical Sciences), Hilary Carswell (Strathclyde Institute of Pharmacy & Biomedical Sciences, University of Strathclyde) and David I Graham (Division of Clinical Neuroscience).
Oestrogen and Stroke
Aims & techniques: Brain aromatase and the influence of oestrogen and oestrogenic drugs on stroke outcome are studied using blood flow techniques, histology & MRI assessment of infarct volume, immunohistochemistry and behavioural testing of sensorimotor function.
Collaborators: Hilary Carswell (Strathclyde Institute of Pharmacy & Biomedical Sciences University of Strathclyde), Karen Horsburgh (Neuroscience, University of Edinburgh), Anna Dominiczak and her group (Division of Cardiovascular and Medical Sciences).
Experimental stroke studies in the spontaneously hypertensive stroke-prone (SHRSP) rat
Techniques: Stroke sensitivity and recovery from stroke in the SHRSP are studied using blood flow techniques, MRI assessment of penumbra, histology & MRI assessment of infarct volume, immunohistochemistry, and behavioural testing of sensorimotor function.
Collaborators: Lorraine Work and Delyth Graham (Institute of Cardiovascular and Medical Sciences), Debbie Dewar and Chris McCabe (Centre for Stroke and Brain Imaging).
Protein GADD34 and its role in Stroke
Aims & techniques: The role of protein GADD34 in brain ischaemia has been studied in rodents, including transgenic GADD34 knock-outs and in human post-mortem brain from stroke and cardiac arrest cases. Histology & MRI are used for quantitation of infarct volume, immunohistochemistry to identify changes in GADD34 protein expression and autoradiography to quantify protein synthesis inhibition in ischaemic brain.
Collaborators: Chris McCabe, David Graham (Division of Clinical Neuroscience), Hide Imai (Gunma University, Japan), S Moira Brown and June Harland (Crusade Laboratories).
White matter damage in Experimental Stroke
Aims & techniques: Rodent models of lacunar stroke and methodology to quantify white matter damage have been developed to study the effects of ischaemia on white matter and the influence of drugs on white matter damage
Collaborators: Hide Imai (Gunma University, Japan), Keith Muir (Division of Clinical Neuroscience) Ken Lees (Division of Cardiovascular and Medical Sciences), Chris Weir (Roberson Centre for Biostatistics), Clotilde Lecrux and Omar Touzani (University of Caen, France)
- Supporting the ischaemic brain with oxygen-carrying perfluorocarbons.
Scottish Executive Health Department
2012 - 2013
- Metabolic MRI in Acute Stroke; Development and Validation of the 'Oxygen Challenge' Technique
Scottish Executive Health Department
2011 - 2013
- Staff Salary
NHS Greater Glasgow & Clyde
2011 - 2011
- Sodium imaging following an "Oxygen Challenge" to assess function of the N/K ATP pump following ischaemia to demonstrate membrane integrity: A novel technique to identify the functional "Penumbra"?
Neurosciences Foundation
2011 - 2012
- Sodium imaging following an "Oxygen Challenge" to assess function of the N/K ATP pump following ischaemia to demonstrate membrane integrity: A novel technique to identify the functional "Penumbra"?
Neurosciences Foundation
2011 - 2012
- Development and application of oscillatory gradient spin echo in stroke animal model at 7T and further validation with histology
Neurosciences Foundation
2011 - 2012
- SINAPSE-SPIRIT: Novel and collaborative approaches to knowledge exchange in translational imaging
Scottish Funding Council
2010 - 2013
- Metabolic syndrome, hyperglycemia and experimental stroke
Scottish Executive Health Department
2009 - 2010
- Development and Validation of an MRI Method to Image Cerebral Metabolism using Oxygen 17.
Neurosciences Foundation
2009 - 2009
- Assessment of Myoglobin as a Novel MR Reporter Gene and its potential to protect Embryonic Stem Cells against hypoxia
Neurosciences Foundation
2009 - 2010
- A combined approach targeting oxidative stress and apoptosis in stroke
British Heart Foundation
2008 - 2012
- Developing a novel diagnostic imaging product for assessing metabolism and its application in stroke
Scottish Enterprise
2008 - 2010
- Imaging the ischaemic penumbra using BOLD MRI with oxygen challenge as a biotracer
MRC
2008 - 2011
- Stem cell research in experimental stroke
British Council, India
2008 - 2009
- Brain'07 & BrainPET'07 the 23rd international symposium on cerebral blood flow, metabolism and quantification of brain function with PET
Royal Society
2007 - 2007
- Characterising the ischaemic penumbra in the SIIRSP and WKY following focal cerebral ischaemia
Neurosciences Foundation
2006 - 2007
- Neuroscience 2006
Royal Society
2006 - 2006
- Targeted gene therapy for cardiovascular disease
MRC
2005 - 2008
- Brain'05 & BrainPET'05 XXIInd International Symposium on Cerebral Blood Flow, Metabolism and Function
Royal Society
2005 - 2005
- Can BOLD MRI imaging with an 02 challenge delineate the ischaemic penumbra in stroke?
Neurosciences Foundation
2005 - 2006
- The role of GADD34 in cerebral ischaemia - an investigation of focal ischaemia in the GADD 34 knockout mouse
Neurosciences Foundation
2005 - 2007
- Non-Invasive Imaging In Neuroscience: Small Bore High Field Magnetic Resonance Facility
Scottish Higher Education Funding Council
2002 - 2007
